Q21* (p.Gln21Ter) variant of PON1 (Serum paraoxonase/arylesterase 1)
Q21* (p.Gln21Ter) in PON1 (Serum paraoxonase/arylesterase 1) is a protein-truncating change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.45 / 1. The record also includes population frequency data and structural context.
Q21* (p.Gln21Ter) variant details
- p.Gln21Ter
- ESP rs148153353
- TOPMed rs148153353
- gnomAD rs148153353
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.446
- CADD 36.00
- Most common in the African/African-American population (allele frequency 0.00017)
- Structural context available